Skip to content
healthcare.dev

Guanfacine

NDC 16714-191, Guanfacine, tablet, extended release, from NORTHSTAR RXLLC.

Product NDC
16714-191
Status
Listed
Labeler
NORTHSTAR RXLLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205689
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16714-191 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUANFACINE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
16714-191-0116714019101100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-191-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0b2afdab-8c92-463e-9734-f2c8b4200777

Use it

Look up 16714-191 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16714-191 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16714-191. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.